Key statistics
As of last trade, Mendus AB (publ) (IMMU:STO) traded at 8.01, 12.87% above the 52 week low of 7.10 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.18 |
---|---|
High | 8.27 |
Low | 8.00 |
Bid | 8.02 |
Offer | 8.25 |
Previous close | 8.18 |
Average volume | 24.34k |
---|---|
Shares outstanding | 50.36m |
Free float | 16.03m |
P/E (TTM) | -- |
Market cap | 418.89m SEK |
EPS (TTM) | -3.00 SEK |
Data delayed at least 15 minutes, as of Nov 26 2024 11:44 GMT.
More ▼
Announcements
- Mendus presenterar framsteg med NK-cellsprogrammet på Innate Killer Summit
- Mendus to present NK cell program progress at the Innate Killer Summit
- Mendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3
- Mendus erhåller avsiktsförklaringar från större ägare och styrelse samt bolagsledning avseende nyttjande av teckningsoptioner av serie TO3
- Nyttjandeperioden för teckningsoptioner av serie TO3 inleds idag
- The exercise period for warrants of series TO3 commences today
- Mendus ger verksamhetsuppdatering och presenterar utsikter för vididencel-programmet
- Mendus provides business update and outlook for vididencel program
- Mendus medverkar på flera branschkonferenser
- Mendus to participate in upcoming industry conferences
More ▼